PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports.
The Latest
Here's a breakdown of how 12 spine and orthopedic companies performed during the second quarter of 2019.
Here are 10 spine and neurosurgeons in the headlines this week.
Richard Meagher, MD, is a neurosurgeon specializing in minimally invasive surgery with Princeton (N.J.) Brain & Spine.
Daniel Penello, MD, successfully implanted a custom 3D-printed finger bone in an iron worker, Robert Smith, who was facing amputation after a heavy steel beam crushed his finger.
Kristopher Kimmell, MD, is a neurosurgeon in Rochester, N.Y., with a practice focused on minimally invasive spine surgery, traumatic brain injury, brain tumors and other spinal procedures.
Thomas Loftus, MD, founder of the Austin (Texas) Neurosurgical Institute, has spent his career focused on complex minimally invasive spine surgery.
The California Institute for Regenerative Medicine has been instrumental in stem cell research since it was first established in 2004, but it faces closure in 2022 if a ballot initiative to get it more funding is unsuccessful.
Alphatec Holdings began the commercial release of its Invictus Minimally Invasive SingleStep K-wireless implant system Aug. 7.
With the rising popularity of outpatient procedures and further innovation in orthopedics, the specialty is becoming a more attractive investment opportunity for private equity firms.